Dainippon Sumitomo Pharma Co., Ltd. – Swot Analysis – Aarkstore Enterprise Market Reserach Report

Dainippon Sumitomo Pharma Co., Ltd. – SWOT Analysis company profile is the essential source for top-level company data and information. Dainippon Sumitomo Pharma Co., Ltd. – SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Dainippon Sumitomo Pharma (DSP) is engaged in the manufacture, sales, purchase, import and export of pharmaceuticals, diagnostics, medical devices, veterinary products, food additives, industrial chemicals, and other chemical products. The company has 11 subsidiaries and seven associated companies. It primarily operates in Japan. The company is headquartered in Osaka, Japan and employs about 4,800 people. The company recorded revenues of JPY263,993 million (approximately $2,317.9 million) during the financial year (FY) ended March 2008, an increase of 1.1% over 2007. The revenue increase during FY2008 was mainly due to growth in the sales of Amlodin, Gasmotin, Prorenal and Meropen. The operating profit of the company was JPY39,814 million (approximately $349.6 million) during FY2008, a decrease of 12.6% over 2007. The net profit was JPY25,592 million (approximately $224.7 million) in FY2008, an increase of 13.2% over 2007.
Scope of the Report
– Provides all the crucial information on Dainippon Sumitomo Pharma Co., Ltd. required for business and competitor intelligence needs
– Contains a study of the major internal and external factors affecting Dainippon Sumitomo Pharma Co., Ltd. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Dainippon Sumitomo Pharma Co., Ltd.
-Data is supplemented with details on Dainippon Sumitomo Pharma Co., Ltd. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Dainippon Sumitomo Pharma Co., Ltd.
Valuable Point :
– Support sales activities by understanding your customers’ businesses better
– Qualify prospective partners and suppliers
– Keep fully up to date on your competitors’ business structure, strategy and prospects
– Obtain the most up to date company information available”
For more information, please visit :
http://www.aarkstore.com/reports/Dainippon-Sumitomo-Pharma-Co-Ltd-SWOT-Analysis-20791.html